KEI comment on the May 5, 2021 USTR statement to support negotiations on a waiver of TRIPS rules for COVID 19 vaccines. Attributed to James Love, KEI Director +1.202.361.3040, james.love@keionline.org KEI applauds the decision by President Biden and USTR Katherine… Continue Reading
KEI will host an online discussion of the new end of Trump term proposals to change Bayh-Dole regulations and Stevenson-Wydler Act statutes, on January 27, 2021, from 2pm to 4pm. To register for the event, send an email to bayh-dole-proposals@keionline.org… Continue Reading
On Friday October 16, 2020, KEI filed a lawsuit (under the Freedom of Information Act) against the Department of Health and Human Services (HHS) and the U.S. Army regarding requests for COVID-19 research and development and procurement contracts awarding hundreds… Continue Reading
On Friday, October 9, 2020, KEI filed a lawsuit in Maryland to obtain documents from five Freedom of Information Act (FOIA) requests filed by KEI related to COVID-19. The cases involve the following issues. The complaint is attached below. FOIA… Continue Reading
(More on KEI’s work on coronavirus here: https://www.keionline.org/coronavirus, and on Moderna, here: https://www.keionline.org/moderna) Oct 8, 2020 Moderna’s statement on intellectual property matters during the COVID-19 pandemic is very good, and should be matched by every manufacturer of a therapeutic, vaccine… Continue Reading
On Friday, September 18, 2020, KEI received a letter from the Defense Advanced Research Projects Agency (DARPA) confirming that the agency was investigating Moderna for failure to report government funding in patent applications. The Financial Times and other outlets had… Continue Reading
Finally there is a text available, and Trump’s Executive Order on international reference pricing is a lot less than promised. Does nothing for most people and nothing at all right now. The operative parts of the Executive Order are limited… Continue Reading
Senator Durbin has written letters to vaccine manufacturers Moderna, AstraZeneca, Sanofi, GlaxoSmithKline, Merck, Pfizer, Novavax, and Janssen/Johnson & Johnson, asking eight detailed questions. Question 8 asked about federal funding of the vaccine, government rights in patents, and the by Bayh-Dole… Continue Reading
(More on Moderna here: https://www.keionline.org/moderna) KEI received a letter Dr. Gary Disbrow, the Acting Director of BARDA, just before noon today. BARDA2KEI.Moderna.Patent.Disclosures.20200903 The BARDA investigation follows the announcement on Saturday that DARPA was also investigating DARPA’s failures to disclose DARPA… Continue Reading
(More on Moderna here: https://www.keionline.org/moderna) Luis Gil Abinader has taken a deep dive into Moderna’s surprising practice of never declaring government funding in its 126 patents and 154 patent applications, despite having had funding from multiple federal agencies. One outcome… Continue Reading